Stem Cells http://www.epitomics.com
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online August 16, 2007
Stem Cells Vol. 25 No. 12 December 2007, pp. 2987 -2995
doi:10.1634/stemcells.2007-0397; www.StemCells.com
© 2007 AlphaMed Press

OPEN ACCESS ARTICLE
This Article
Free via Open Access: OA
Right arrow OA Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrowOA All Versions of this Article:
2007-0397v1
25/12/2987    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, X.
Right arrow Articles by Claesson-Welsh, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, X.
Right arrow Articles by Claesson-Welsh, L.

EMBRYONIC STEM CELLS

Lentiviral Rescue of Vascular Endothelial Growth Factor Receptor-2 Expression in Flk1–/– Embryonic Stem Cells Shows Early Priming of Endothelial Precursors

Xiujuan Lia, Dan Edholma, Fredrik Lannerb, Georg Breierc, Filip Farnebob, Anna Dimberga, Lena Claesson-Welsha

aRudbeck Laboratory, Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden;
bDepartment of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden;
cInstitute of Pathology, Technische Universität Dresden-Faculty of Medicine "Carl Gustav Carus," Dresden, Germany

Key Words. Vascular endothelial growth factor receptor-2 • Flk1 • Vascular endothelial growth factor • Stem cells • Embryoid bodies Differentiation • Endothelial cells • Angiogenesis

Correspondence: Lena Claesson-Welsh, Ph.D., Rudbeck Laboratory, Department Genetics and Pathology, Uppsala University, Dag Hammarskjöldsv. 20, 751 85 Uppsala, Sweden. Telephone: 46-18-471-4363; Fax: 46-18-55-89-31; e-mail: Lena.Welsh{at}genpat.uu.se

Received May 22, 2007; accepted for publication July 31, 2007.
First published online in STEM CELLS EXPRESS   August 16, 2007.



The vascular endothelial growth factor (VEGF) family and its receptors are important for vascular development and maintenance of blood vessels, as well as for angiogenesis, the formation of new vessels. Loss of VEGF receptor-2 (VEGFR-2; designated Flk-1 in mouse) results in arrest of vascular and hematopoietic development in vivo. We used lentiviral transduction to reconstitute VEGFR-2 expression in flk1–/– embryonic stem (ES) cells. VEGF-induced vasculogenesis and sprouting angiogenesis were rescued in transduced ES cultures differentiating in vitro as EBs. Although the transgene was expressed in the pluripotent stem cells and lacked linage restriction during differentiation, the extent of endothelial recruitment was similar to that in wild-type EBs. Reconstitution of VEGFR-2 in flk1–/– ES cells allowed only precommitted precursors to differentiate into functional endothelial cells able to organize into vascular structures. Chimeric EB cultures composed of wild-type ES cells mixed with flk1–/– ES cells or reconstituted VEGFR-2-expressing ES cells were created. In the chimeric cultures, flk1–/– endothelial precursors were excluded from wild-type vessel structures, whereas reconstituted VEGFR-2-expressing precursors became integrated together with wild-type endothelial cells to form chimeric vessels. We conclude that maturation of endothelial precursors, as well as organization into vascular structures, requires expression of VEGFR-2.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
Cancer Res.Home page
H. Kawamura, X. Li, S. J. Harper, D. O. Bates, and L. Claesson-Welsh
Vascular Endothelial Growth Factor (VEGF)-A165b Is a Weak In vitro Agonist for VEGF Receptor-2 Due to Lack of Coreceptor Binding and Deficient Regulation of Kinase Activity
Cancer Res., June 15, 2008; 68(12): 4683 - 4692.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.stemcellsportal.com/
Copyright © 2007 by AlphaMed Press.